86 related articles for article (PubMed ID: 9625826)
1. Effect of the nitrosourea anti-tumor chemotherapeutical agent MCNU on five human myeloma cell lines.
Otsuki T; Sakaguchi H; Yamada O; Yawata Y; Ueki A
Oncol Rep; 1998; 5(4):827-32. PubMed ID: 9625826
[TBL] [Abstract][Full Text] [Related]
2. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
4. [Effect of MCNU on growth kinetics of human plasma cell lines--in comparison with melphalan].
Ohnaka T; Ohno T; Kanoh T; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1987 Aug; 50(5):971-7. PubMed ID: 3434146
[No Abstract] [Full Text] [Related]
5. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
Kochi M; Takaki S; Kuratsu J; Seto H; Kitamura I; Ushio Y
J Neurooncol; 1994; 19(3):239-44. PubMed ID: 7807174
[TBL] [Abstract][Full Text] [Related]
7. Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis.
Asano Y; Shimokawa M; Okabe H; Sanefuji H; Kato K
Acta Haematol; 1991; 85(2):103-4. PubMed ID: 2024552
[TBL] [Abstract][Full Text] [Related]
8. Biologic activity of MCNU: a new antitumor agent.
Sekido S; Ninomiya K; Iwasaki M
Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
[TBL] [Abstract][Full Text] [Related]
9. [Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Masaoka T; Kimura K; Miyazaki T; Sakurada K; Saitoh H; Morioka M; Fujimoto N; Musashi M; Wakui A; Yokoyama M; Kanamaru R; Oguro M; Takagi T; Konda C; Saitoh T; Nakao I; Harashima S; Ohhashi Y; Sakai Y; Sasaki T; Ohno R; Katoh Y; Yamada K; Hirota Y; Takada T; Hoshino A; Ohara K; Kamiya O; Kojima T; Nagata K; Nakamura T; Sasada M; Yonezawa T; Tsubakio T; Kanayama Y; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A; Horiuchi A; Tsubaki K; Takubo T; Shibata H; Kawagoe H; Hirata M; Matsubuchi T; Nagai K; Fujita S
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1518-23. PubMed ID: 6347081
[TBL] [Abstract][Full Text] [Related]
10. A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
Hiraoka A; Masaoka T; Shibata H; Miyazaki T; Nakamura T; Yasunaga K; Kitani T; Yonezawa T; Kawagoe H; Horiuchi A
Leuk Res; 1988; 12(6):487-90. PubMed ID: 3043111
[TBL] [Abstract][Full Text] [Related]
11. [Action mechanism of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in leukemic cells].
Nakamura T; Hashimoto E; Sasada M; Tsutani H; Kagawa D; Ueda T; Uchida M; Domae N; Ando S; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1985 May; 48(3):734-41. PubMed ID: 3862320
[No Abstract] [Full Text] [Related]
12. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
Masaoka T; Kimura K; Miyazaki T; Hirota Y; Nakamura T; Yasunaga K; Ohkubo H; Okamoto Y; Fujitake H; Kitani T
Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
[TBL] [Abstract][Full Text] [Related]
13. [Discriminant analysis of bone marrow suppression of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Saito A; Oride M; Munaka M; Uozumi T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):511-5. PubMed ID: 3813579
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
[TBL] [Abstract][Full Text] [Related]
15. [Establishment and characterization of five human myeloma cell lines].
Ohtsuki T; Yawata Y; Namba M
Hum Cell; 1989 Sep; 2(3):297-303. PubMed ID: 2519219
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
Kobayashi T; Tanaka I; Shirakawa S; Fujiwara Y; Hirota Y; Kobayashi M; Ohno R; Yamada H; Mitomo Y; Yamamoto M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1079-85. PubMed ID: 3566304
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological studies on MCNU: a new antitumor agent].
Sekido S; Hosono J; Hiratsuka K; Araki T; Iwasaki M
Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):69-96. PubMed ID: 3224900
[TBL] [Abstract][Full Text] [Related]
18. Review of experimental studies on nitrosourea derivatives in Japan.
Tsukagoshi S
Recent Results Cancer Res; 1980; 70():107-17. PubMed ID: 7355242
[TBL] [Abstract][Full Text] [Related]
19. [Prolonged remission in a patient with chronic myelocytic leukemia (CML) by methyl 6-[3-(2-chloroethyl)-3-deoxy-alpha-D-glucopyranoside (MCNU)].
Murase T; Nagura E; Ohno R
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2590-3. PubMed ID: 6594976
[TBL] [Abstract][Full Text] [Related]
20. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
